Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (801-810 of 829) with videos related to

Pageof 83
Sort By:
Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.
Immunity|December 1, 2021
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesMohamad-Gabriel Alameh, István Tombácz, Emily Bettini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic CancerJoan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic CancerAndrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Journal of Hepatology|June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infectionMark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Pageof 83

Showing results (801-810 of 829) with videos related to

Sort By:
Pageof 83
Journal of Gastroenterology and Hepatology|January 31, 2018
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in ChinaLai Wei, Qing Xie, Jin Lin Hou, et al.
Immunity|December 1, 2021
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesMohamad-Gabriel Alameh, István Tombácz, Emily Bettini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic CancerJoan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
Genome Medicine|October 27, 2016
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy L Stockley, Amit M Oza, Hal K Berman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal AdenocarcinomaMartin R Jones, Laura M Williamson, James T Topham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic CancerAndrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Journal of Hepatology|June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infectionMark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Pageof 83